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Abstract
Delivery of diagnostic or therapeutic agents across the blood-brain barrier (BBB) remains a major challenge of brain
disease treatment. Magnetic nanoparticles are actively being developed as drug carriers due to magnetic targeting and
subsequently reduced off-target effects. In this paper, we developed a magnetic SiO2@Fe3O4 nanoparticle-based carrier
bound to cell-penetrating peptide Tat (SiO2@Fe3O4
-Tat) and studied its fates in accessing BBB. SiO2@Fe3O4-Tat
nanoparticles (NPs) exhibited suitable magnetism and good biocompatibility. NPs adding to the apical chamber of in
vitro BBB model were found in the U251 glioma cells co-cultured at the bottom of the Transwell, indicating that particles
passed through the barrier and taken up by glioma cells. Moreover, the synergistic effects of Tat and magnetic field
could promote the efficient cellular internalization and the permeability across the barrier. Besides, functionalization with
Tat peptide allowed particles to locate into the nucleus of U251 cells than the non-conjugated NPs. These results
suggest that SiO2@Fe3O4-Tat NPs could penetrate the BBB through the transcytosis of brain endothelial cells and
magnetically mediated dragging. Therefore, SiO2@Fe3O4-Tat NPs could be exploited as a potential drug delivery system
for chemotherapy and gene therapy of brain disease.
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Background
The blood-brain barrier (BBB) comprised of brain capillary
endothelial cells is the most restrictive barrier in vivo that
hampers the transport of s ubstances from the peripheral
circulation to the brain and helps maintain brain homeosta-
sis [1]. However, essentially 98 % of small-molecule drugs
and 100 % of large-molecule drugs do not pass through the
physiologic barrier that inhibit drug delivery from blood
circulation to brain tissue [2, 3]. Therefore, the development
of a novel drug delivery system to aid drugs across the BBB
is the crucial point of the treatment of many brain diseases.
Currently, different strategies for bypassing the BBB
have been developed, including direct injection into the
brain, transient disruption of the BBB, inhibition of
efflux pumps, pro-drug strategy, and receptor-mediated
transcytosis [4–8]. Nanoparticle-based delivery system
has been proved an advantage in effective transportation
of various drugs across BBB [9–11], especially iron oxide
nanoparticles (IONPs) have attracted significant import-
ance in the last decade due to their intrinsic magneto-
phoretic mobility, which enable targeting the lesions by
magnetic guidance and reducing off-target effects [12].
Because of high surface-to-volume and the magnetic
interaction, bare IONPs tended to aggregate and lower
magnetic responds by oxidation, which induce a limited
drug targeting [13]. Several biocompatible polymers, such
as PEG, chitosan, alginate, dextran, and fetal calf serum,
have been used to stabilize Fe3O4 particles and further
functionalize [14–16]. Among all the possible surface
modifications for IONPs, silica (SiO2) coating was sup-
posed especially suitable to be employed for medical
purposes due to high pore volume, good biocompatibility,
and its transparency [17, 18]. It has been proved that silica
coating on IONPs improves cellular uptake and achieves
targeted delivery of drug under magnetic field condition
[19, 20]. However, low efficiency of permeability and accu-
mulation in the brain is still a great issue.
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Cationic cell-penetrating peptides (CPPs) can facilitate
the internalization of attached macromolecules and even
nano-carriers (e.g., polymers, liposomes) by various cells via
independent transporters and receptor-mediated endocyto-
sis [21, 22]. A number of CPPs including trans-activating
transcriptional activator (TAT), angiopep, penetratin, rabies
virus glycoprotein (RVG), prion peptide, and SynB have
already been demonstrated the ability of improving
drug delivery across the BBB [23, 24]. Peptide Tat
(YGRKKRRQRRR), derived from TAT protein, can
increase the permeability of brain endothelial cells by
inhibiting occludin expression and cleaving occludin via
matrix metalloproteinase-9 [25]. It has been demon-
strated that Tat-conjugated nanoparticles can deliver
siRNA and drug across the BBB to kill intracerebral
malignant glioma cells and further extend the mouse
life span [26]. On the other hand, the permeation
mechanism and the precise location of the particles
across the BBB remain poorly understood at a cellular
level [27]. In vitro BBB model may keep the status of
BBB integrity, which helps to be understood in terms of
how BBB facilitate or interfere with drug delivery [28].
In the present study, we developed a novel core-shell
structured magnetic Tat-conjugated SiO2@Fe3O4 nano-
particles (NPs). This study aimed to evaluate the nano-
particles’ permeability across BBB and their fates in
accessing BBB as shown in Scheme 1. Human brain
endothelial cell (hCMEC) monolayer and hCMEC/
U251 co-culture model were used to examine cellular
uptake, BBB permeability, and subsequently location
in U251 cells in the absence and presence of a mag-
netic field. Besides, the physicochemical properties,
cytotoxicity, and the integrity of monolayer were also
investigated. The studies of systematic effect of cell-
penetrating peptide and magnetic field on mediating
BBB permeability and internalization into brain endo-
thelial cells may aid to design peptide-functionalized
magnetic NPs for brain targeting in the future.
Methods
Materials and Cell Lines
Tetraethyl orthosilicate (TEOS), ferrous chloride (FeCl3),
ferric chloride (FeCl2), and sodium citrate were purchased
from Xilong Chemical Co., Ltd. (Shantou, China). 3-
Aminopropyl-trimethoxysilane (APTMS) was purchased
from Acros Organics (Belgium, USA).
N-Hydroxy sulfo-succinimide (NHS), 1-(3-(dimethyla-
mino)-propyl)-3-ethylcarbodiimide hydrochloride (EDC),
and FITC-labeled Tat (Tyr-Gly-Arg-Lys-Lys-Arg-Arg-
Gln-Arg-Arg-Arg) peptide were provided by Gier
Biochemistry Co., Ltd. (Shanghai, China). BCA protein
assay kit was purchased from Applygen Technologies
Inc. (Beijing, China). External magnetic field was applied
by placing an Nd–Fe–B magnet under the culture plates
Scheme 1 Design and synthesis of Fe3O4@SiO2-Tat magnetic NPs to enhance the permeability across the BBB
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using an immobilized tube apparatus. Human glioma
cell lines U251 and human brain capillary endothelial
cells hCMEC/D3 (abbreviated as hCMEC) were pur-
chased from BeNa Culture Collection (Beijing, China).
All the cells were cultured in RPMI-1640 media with
10 % fetal bovine serum, 10 % penicillin, and 10 %
streptomycin at 37 °C in CO2 incubator.
Synthesis of Tat-SiO2@Fe3O4 NPs
The magnetic Tat-SiO2@Fe3O4 NPs were synthesized as
the following steps. The superparamagnetic Fe3O4 NPs
were synthesized firstly by alkaline co-precipitation [29].
Under vigorous stirring at 80 °C, ammonia water was
dropped into the mixture solution of Fe(II) and Fe(III)
(molar ratio = 2:1) till the pH 10. After 20 min of contin-
ued stirring, sodium citrate (Na3Cit) was added into the
mixture at 40 °C with stirring for 90 min under N2 protec-
tion to obtain black magnetite Fe3O4 NPs. Secondly, SiO2-
coated Fe3O4 NPs (SiO2@Fe3O4 NPs) were prepared by
the Stöber method [30]. The as-prepared 10 mg of Fe3O4
NPs was ultrasonically dispersed into a mixture of etha-
nol/water solution (50.7 mL; v:v, 50:0.7), TEOS(0.3 mL),
and NH4OH (1.7 mL) and then continuously stirred for
3 h. The obtained NPs were collected using an external
magnet and washed sequentially with water and ethanol.
Thirdly, the 10 mg SiO2@Fe3O4 NPs was re-dispersed into
10 mL ethanol, and 500 μL of APTMS was added and
stirred for 24 h under N2 protection at room temperature
to introduce amino-silane coating of SiO2@Fe3O4 NPs.
Finally, EDC-NHS coupling was used for the attachment
of the Tat peptide to amino-functionalized NPs. The as-
prepared 100 μL of amino-SiO2@Fe3O4 NPs (1 mg/mL)
was activated using EDC (4 nmol) and NHS (4 nmol).
Then, 10 μL of FITC-Tat peptide (1 mg/mL) was added to
the mixture and stirred for 3 h under N2 protection at
room temperature to obtain the final Tat-conjugated
SiO2@Fe3O4 NPs (Tat-SiO2@Fe3O4 NPs) which were
lyophilized for further observation after centrifugation and
washing with water.
Characterizations of Nanoparticles
The morphology of synthesized nanoparticles was charac-
terized under a Philips JEM-2100HC transmission electron
microscope (TEM) with an accelerating voltage of 150 kV.
X-ray powder diffraction (XRD) patterns were recorded on
an X’Pert-Pro diffractometer (PANalytical, Holland) in the
2q range from 20° to 80°. Element analysis was carried on a
PHI-Quantum 2000 X-ray photoelectron spectroscopy
(Physical Electronics, Inc, Japan). The hydrodynamic diam-
eter and zeta potential of the as-synthesized NPs were mea-
sured on a Nano-ZS Zetasizer dynamic light scattering
(DLS) detector (Malvern Instruments, UK), and the results
were analyzed using the Malvern Zetasizer software assum-
ing a log normal distribution. The magnetic properties of
the products were characterized by vibrating sample
magnetometry (VSM) in an applied magnetic field
sweeping from −18 to 18 kOe. The elemental composition
of the nanoparticles was characterized by Quantum 2000
X-ray photoelectron spectroscopy (XPS, PHI, US). Fourier
transform infrared spectroscopy (FTIR) spectra of the
samples were recorded on Nicolet-APTMSVATAR360
spectrometer in the range 4000–400 cm−1 using the KBr-
disk method. The thermo-gravimetric analysis (TGA) was
taken at a heating rate of 10 °C min−1 in a nitrogen at-
mosphere with a Pyris Diamond TGA thermal analyzer
(PerkinElmer, Massachusetts, USA).
Additionally, iron content in nanoparticles or cell sam-
ples was determined by a colorimetric assay based on
chromogenic reaction of Fe(III) with potassium thiocyan-
ate. For a typical sample, 0.1 mL suspension was succes-
sively incubated with sodium hydroxide (0.1 mL, 5 mol/L)
for 1 h at 80 °C, concentrated hydrochloric acid (0.1 mL,
12 mol/L) for 2 h at 55 °C, and excess ammonium persul-
fate (100 μg/mL) for 15 min at room temperature to re-
move SiO2 coating and oxidize Fe element in samples into
Fe(III). After 10 min incubation of Fe(III) with potassium
thiocyanate (0.1 mol/L), a red complex iron-thiocyanate
form and the absorbance were detected using UV-vis
spectrophotometer at the wavelength of 478 nm. Serial
Fe(III) dilutions in the range 0–80 μg/mL were prepared
to obtain a standard. Then, Fe content in sample is calcu-
lated as the absorbance from a standard curve. In the
following experiments, amount of NPs was directly
accounted as content.
Construction and Characterization of BBB Models
To construct the BBB models, hCMEC cells were seeded
on uncoated PET membrane of Transwell filter insides
(1 μm pore size) in 500 μL medium at 1 × 105 cells/well.
Cells were cultured with the RPMI 1640 medium at 37 °
C and in 5 % CO2, and the medium was changed every
2 days. After 7–10 days, a confluent hCMEC monolayer
was generated. U251 cell monolayer was selected as the
control.
For the characterization of the BBB model, the cell
morphology of monolayer was initially observed by
phase contrast optical microscopy. Immune-staining of
tight junction-associated protein ZO-1 was performed
to determine the BBB tight junction. Briefly, the cell
monolayer on Transwell inserts was clipped and
washed with PBS and then fixed in 4 % paraformalcle-
hyde for 30 min and blocked with 1 % BSA for further
30 min. After washing with PBS, a monoclonal rabbit
anti-ZO-1 antibody (diluted 1/50 in 1 % BSA in PBS,
300 μL) was added and incubated for 30 min. Next,
TRITC conjugated mouse anti-rabbit IgG (diluted 1/50
in 1 % BSA in PBS, 300 μL) was added and incubated
for 1 h. After washing the cells, the samples were
Zhao et al. Nanoscale Research Letters  (2016) 11:451 Page 3 of 12
stained with Hoechst (10 μg/mL, 300 μL). The tightness
of the cellular barrier is further assessed by transen-
dothelial electrical resistance (TEER) of monolayer.
Only the monolayers with TEER over 150Ω were used
for studies.
BBB permeability was estimated by examining the
transport of disodium salt (Na-F) and horseradish perox-
idase (HRP) through monolayers for various periods.
Fluorescence microcopy was used to examine the
amount of Na-F. Permeability coefficient (Pe) values of
Na-F through BBB mode can be determined by the
equation 1P ¼ 1Pt − 1Pf where Pt and Pf correspond to the
permeability coefficient values of Na-F through cell
monolayer and control filter, respectively. HRP penetra-
tion of monolayers was examined as previously reported
[31]. The experiment was repeated three times.
Cytotoxicity
MTT assay was used to access in vitro cytotoxicity. The
hCMEC cells were seeded into 96-well plate at 5 × 103
cells/well and incubated for 24 h till the 70 % conflu-
ence. Then, Fe3O4@SiO2-Tat or Fe3O4@SiO2-Amino
NPs with different concentrations (100, 200, 400, 600,
and 800 μg/mL) were added to each well. The untreated
hCMEC cells were used as control. After another 24 h
incubating, a standard MTT was carried out according
to the instructions.
In Vitro Uptake Study Under Magnetic Field
The hCMEC cells were seeded in a 24-well plate at 2 × 105
cells/well and cultured overnight. The cells were treated
with 100 μg of Fe3O4@SiO2-Amino or Fe3O4@SiO2-Tat
NPs with external magnetic field placed with a magnet on
cell plate for varied periods (0, 0.5, and 2). After incuba-
tion for a further periods (2 or 12 h), the cells were
washed with PBS, then lysed. Total protein concentration
was determined using the BCA protein assay kit. Uptake
amounts of NPs were determined through measuring the
element Fe.
BBB Transport Experiment
For quantifying BBB penetrating efficiency, the hCMEC
monolayers with TEER value over 150 Ω cm2 were se-
lected as the BBB model of hCMEC cells. Two hundred
micrograms of Fe3O4@SiO2-Amino or Fe3O4@SiO2-Tat
NPs was added into the apical chambers and incubated
for 24 h. Then, each well was irradiated with external
magnetic field for varied periods (0, 0.5, 2, and 8 h).
RPMI 1640 medium was used as the blank control. After
removing external magnetic field, the NPs were added
and incubated for another 26 h. TEER of monolayer was
detected in the interval of 1 h and a plot of the TEER—-
time curve was made. After washing with PBS, the
hCMEC cells for each variable (NPs only, NPs +magnet
and irradiation time) were lysed and transportation effi-
ciency was assessed through determining the ratio of the
element Fe in bottom chambers.
Penetrating Through a hCMEC Monolayer and Further
Location in U251 Cells
For construction of co-culture BBB models, hCMEC cells
were seeded on Transwell insides at a density of 1 × 105
cells and incubated for about 8 days to form a compact
monolayer. Subsequently, U251 glioma cells were seed at
the bottom of the Transwell at 1.5 × 105 cells/well and cul-
tured for 24 h till the 70 % confluence. Until the resistance
of hCMEC monolayer was examined over 150 Ω cm2,
200 μg of FITC-labeled Fe3O4@SiO2-Amino and Fe3O4@-
SiO2-Tat NPs was added to the apical chambers of the
BBB models. Subsequently, each well was irradiated for
2 h under external magnetic field. After incubation for
another 24 h, U251 cells on the bottom chambers were
washed in PBS and harvested. To determine the penetra-
tion ability of NPs, the cells for each variable FITC-labeled
NPs (NPs only and NPs +magnet) were collected and the
penetrating ability was evaluated though quantifying the
cellular uptake of the U251 cells with a flow cytometer
(Beckman Coulter, USA). Additionally, confocal laser
scanning microscope (CLSM) is also used for observation
the internalization and location of FITC-labeled NPs. The
cells for each variable FITC-labeled NPs (NPs only and
NPs +magnet) were collected and fixed with paraformal-
dehyde (4 % in PBS) for 30 min. Then, cells were treated
with Hoechst 33258 (10 mg/mL) for 20 min to stain the
nucleus. An inverted CLSM (FluoviewFV1000, Olympus,
Japan) equipped with a Plan-Apochromat 60 × 0.7 NA
lens was used to observe the samples.
Statistical Analysis
Statistical analysis was conducted using a two-tailed
unpaired Student’s t test. The results were presented as
mean ± standard deviation.
Results and Discussion
Synthesis and Characterization of NPs
The strategy to prepare core-shell SiO2@Fe3O4-Tat NPs
involves four steps, consisting of synthesis of Fe3O4
nanoparticles by co-precipitation, growth of a silica shell,
surface amination, followed by conjugation of Tat pep-
tide through EDC/NHS coupling reactions, as depicted
in Scheme 1. Fe3O4 NPs were easily coated with a uni-
form SiO2 shell by the Stöber method [30]. TEM image
in Fig. 1a revealed a spheroid and uniform morphology
of the Fe3O4@SiO2 NP. An approximately 20 nm of
black central portion of the probe is the magnetic
nucleus with a larger electron density, and the surround-
ing gray portion of 4 nm thick is the amorphous SiO2
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wrap. XRD patterns of the Fe3O4, Fe3O4@SiO2 NPs, and
Fe3O4@SiO2-Amino NPs are shown in Fig. 1b. Six dif-
fraction peaks at 2θ = 30.4, 35.7, 43.4, 53.7, 57.4, and
62.7 corresponded to the (220), (311), (400), (422), (511),
and (440) planes of the inverse cubic spinel structure of
Fe3O4, respectively (JCPDS card no. 09-0432). The pres-
ence of a broader peak at 2θ = 23 illustrated the amorph-
ous silica coating on Fe3O4 NPs. No evident differences
were observed for Fe3O4@SiO2 and Fe3O4@SiO2-Amino
NPs, suggesting that amino modification of Fe3O4 NPs
did not lead to any crystal phase change.
Successive introduction of amino group was confirmed
by FTIR analyses. FTIR spectra of the Fe3O4, Fe3O4@-
SiO2, and Fe3O4@SiO2-Amino NPs were examined and
shown in Fig. 1c. The characteristic bands at 582 cm−1
corresponded to the vibration of the Fe–O bonds. The
bands at 1617 and 1401 cm−1 were assigned to the
stretching vibrations of carboxyl salt, suggesting the
presence of coordinative effect in the Fe (III)-carboxylate
group [32]. The characteristic absorption bands at 1096,
799, and 467 cm−1 for Si–O–Si group confirmed that
the Fe3O4 NPs were encapsulated by a layer of silica.
The IR spectrum of Fe3O4@SiO2-Amino NPs showed
that the weak bands at 1549 cm−1 belonged to the bend-
ing vibration of amine group and two broad bands at
2984 and 2927 cm−1 corresponded to C–H stretching
vibration. The presence of a band at 798 cm−1 may be
attributed to the Si–C stretching vibrations, indicating
the conjugation of amide groups with the silica frame-
work via the APTES hydrolysis [33]. Moreover, the XPS
was used to explore the elemental compositions of func-
tional Fe3O4 NPs. As shown in Fig. 2, the Fe 2p and Si
2p XPS patterns appeared on spectrum of bare Fe3O4
and Fe3O4@SiO2 NPs, respectively, which can be
assigned to SiO2 coating. The N1s binding energy peak
at 397.5 eV only was presented in XPS spectrum of
Fe3O4@SiO2-Amino NPs, suggesting successful APTES
conjugation. It is also found that a peak at 284.9 eV on
total scan spectra can be assigned to C–C bonds of cit-
rate ions [33].
Peptide Tat was covalently immobilized onto activated
magnetic nanoparticles with EDC/NHS as shown in
Scheme 1. FITC-labeled Tat peptide was used in the
synthesis process to confirm the conjugation of Tat
peptide. An obvious absorbance at 520 nm in the fluor-
escence spectrum of Fe3O4@SiO2-Tat NPs indicated the
successfully conjugation of Tat peptide on the surface
(Fig. 3a). TGA was used to quantitatively characterize
the modification efficiency of Tat peptide onto the sur-
face of Fe3O4@SiO2 NPs. TGA curves of Fe3O4@SiO2-
Tat NPs in Fig. 3b showed three transitions during the
temperature of (i) 25–100 °C, (ii) 100–230 °C, and (iii)
Fig. 1 a TEM images of Fe3O4@SiO2 NPs; b the X-ray diffraction patterns; and c the FTIR spectra of Fe3O4, Fe3O4@SiO2, and Fe3O4@SiO2-Amino NPs
Fig. 2 a XPS survey scan spectra; b Fe2p, c Si2p, and d N1s of Fe3O4, Fe3O4@SiO2, and Fe3O4@SiO2-Amino NPs
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230–550 °C. The first weight loss of 2.51 % was asso-
ciated to the surface water removal, the second one
(1.73 %) indicated the decomposition of Tat peptide,
while the last section (3.30 %) corresponded to the
thermal decomposition of grafted APTES. No further
weight loss occurred with the increase of temperature
and total organic matters of Fe3O4@SiO2-Tat NP
weighted for 5.03 %.
Surface modification changes the particle size and sur-
face charge but also influences the uptake ability and
pathway of NPs into the cells. As shown in Table 1,
hydrodynamic size of Fe3O4, Fe3O4@SiO2, and Fe3O4@-
SiO2-Amino and Fe3O4@SiO2-Tat NPs (23.7, −72.8, 76.4,
and 87.6 nm, respectively) gradually increased along
with the functionalization procedure. The larger hydro-
dynamic sizes than TEM values may be due that DLS
measures large aggregates in aqueous solution while
TEM just measures single Fe3O4 NP. On the other hand,
Fe3O4@SiO2 NPs showed less negative charges
(−15.4 mV) than that of bare Fe3O4 NPs (−23.7 mV)
due to the shielding effect of silica coating on citrate
ions. And, the remaining negativity might be attributed
to the existence of a large amount of silanol groups on
surface. After surface amination of APTES, the zeta
potential of Fe3O4@SiO2-Amino NPs become toward
positive position (24.9 mV) due to the introduction of
amino. After further conjugating with cationic peptide
Tat, the averaged zeta potential was 42.1 mV, which was
beneficial to efficient entrapment of negative cell
delivery.
Finally, the magnetic properties of the three types of
modified MNPs mentioned above were measured by
VSM at room temperature. No remnant magnetization
and hysteresis were shown in Fig. 4, suggesting their super-
paramagnetic property. The saturation magnetization (Ms)
of Fe3O4@SiO2, Fe3O4@SiO2-Amino, and Fe3O4@SiO2-Tat
NPs were 27.4, 22.1, and 19.21 emu g−1, respectively. The
gradual decrease in Ms is due to an increase in the thick-
ness of Fe3O4 coating along with the functionalization
procedure. And, magnetic response of Fe3O4@SiO2-Tat
NPs was large enough to quickly separate particles from
solution by the magnet (Fig. 4, inset). This property could
endow Fe3O4@SiO2-Tat NPs with magnetically mediated
tumor targeting.
Characterization of the BBB Model
The confluent hCMEC monolayers were used to prepare
in vitro BBB model which can be assessed through some
indicators such as morphological, tight junction protein
Fig. 3 a The fluorescence spectra of Fe3O4@SiO2-Amino and Fe3O4@SiO2-Tat NPs. b The TG and DTG curves of Fe3O4@SiO2-Tat NPs
Table 1 Zeta potential and particle size
Nanoparticles Zeta potential (mV) Size (nm)
Fe3O4 −23.7 ± 1.87 23.7 ± 2.06
Fe3O4@SiO2 −15.4 ± 1.05 72.8 ± 2.54
Amino-Fe3O4@SiO2 24.9 ± 2.05 76.4 ± 1.27
Tat-Fe3O4@SiO2 42.1 ± 2.25 87.6 ± 3.23
Fig. 4 Normalized magnetization curves of Fe3O4@SiO2, Fe3O4@SiO2-
Amino, and Fe3O4@SiO2-Tat NPs
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staining, TEER value measurements, and permeability
studies.
As shown in Fig. 5a, on day 8 of culture, the confluent
hCMEC cells form a monolayer without aperture as it
was seen on a phase contrast optical microscopy. The
high expression of zonula occludens was the characteris-
tic of the confluent brain endothelial cell monolayers.
An immune-staining of the endothelial specific tight
junction protein ZO1 (Fig. 5b, c) revealed an increasing
amount of punctuated fluorescence at intracellular re-
gions along with the growth of cells, which confirmed
that the tight junctions had been correctly assembled.
BBB integrity was evaluated using Na-F and HRP
exogenous tracers [34]. PS values of Na-F were calcu-
lated to be 1.66 and 23.84 × 10−3 cm/min for hCMEC
and U251 cells, respectively (data not shown), in accord-
ance with previously published data [35]. The permeabil-
ity of HRP on BBB is only 1.05 % within 10 h, while up
to 50 % of HRP had transfer across monolayer of U251
cells and the value increased with longing time (Fig. 5d).
The low permeability of hCMEC monolayer meant a
strong restriction for small hydrophilic molecules and
macromolecule tracers, illustrating the tightening of
BBB model.
The TEER is commonly used to assess the integrity of
brain endothelial cell monolayer. Previous studies indi-
cated that over 120 Ω × cm2 of TEER value can account
for the in vitro BBB integrity [36]. In our model, a
higher TEER value above 150 Ω × cm2 was monitored
on 8 days and it will not change evidently in the next
week (Fig. 5e), suggesting the confluent monolayer
could be used as an in vitro model for exploring the
NPs transport.
In Vitro Cytotoxicity
The cytotoxicity of NPs remains a matter of concern in
their application as drug carrier. MTT assay was com-
monly used to determine the cytotoxicity in a
concentration-dependent manner. As shown in Fig. 6,
Fe3O4@SiO2-Tat and Fe3O4@SiO2-Amino NPs main-
tained above 70 % of the cell viability in the tested
concentrations, and the cytotoxicity appeared in dose-
dependent manner. Besides, Tat-conjugated NPs showed
a slight decrease of cell viability relative to Fe3O4@SiO2-
Amino NPs, due to a reduced membrane trans-locating
activity from Tat [37]. During the tested concentrations
below 800 mg/mL, the NPs were non-cytotoxic.
Fig. 5 a Images of BBB model at the eighth day; immune-staining of tight joint—ZO-1 for hCMEC monolayer (b) and U251 control (c) at the
eighth day; d The permeability of HRP. e TEER measurement on the hCMEC monolayer, U251 monolayer, and PET membrane control. Bar: 50 μm
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In Vitro Uptake Study Under Magnetic Field
To evaluate the possibility of NPs across the BBB, we
first determined whether Fe3O4@SiO2-Tat NPs can be
internalized into brain endothelial cells in the present or
absent of magnetic field. Flow cytometry experiments
were used to quantity the internalization of the Tat-
conjugated and non-conjugated NPs inside the cells.
The different cell uptake percentage has been displayed
in Fig. 7, as a result of the differently grafted group and ex-
plosion time to magnetic field. When a magnetic force
was exerted for 0.5 or 2 h, cell internalization had been
shown to increase by 1.8/2.6 times for Fe3O4@SiO2-Tat
NPs and 1.5/3.5 times for Fe3O4@SiO2-Amino NPs,
respectively. The result suggested a magnet aid endocyto-
sis process. Moreover, the cellular uptake of both NPs by
hCMEC cells was increased by two to three times with
incubation time prolonging from 2 to 12 h, indicating a
time-dependent cellular internalization. Besides, it has also
been found that conjugation with peptide Tat could
enhance by 1.2–2.2 times cellular uptake on varied explo-
sion time (0–2 h) relative to Fe3O4@SiO2-Amino NPs,
suggesting that Tat peptide could increase internalization
efficiency of NPs into brain capillary endothelial cells by
Tat-mediated membrane destabilization.
Passage of NPs Through BBB
A major problem of targeting the brain lies in the poor
BBB penetration. Therefore, the transport of NPs over
the BBB is a critical issue. In our experiment, NPs were
added in the apical chamber of in vitro BBB model. If
transcytosis of NPs occurs, they will transfer across the
filters of Transwell and then be found in the bottom
chamber. By analyzing the ratio of trans-cellular nano-
particles to adding amount, we can rank their transport
efficiencies.
It is indicated from Fig. 8 that both NPs are able to
effectively cross over BBB in the absence of magnetic
field. And, transport efficiencies were increased with
exposure time of magnetic field longing. Fe3O4@SiO2-
Amino increased 17 % passage ratio after applying a
magnetic force for 8 h, while Fe3O4@SiO2-Tat NPs was
enhanced 1.8-, 2.3-, and 2.8-fold at the exposure periods
of 0.5, 2, and 8 h, respectively, compared with that with-
out external magnetic force. This result indicated a mag-
netic field-increased permeability of NPs across hCMEC
monolayer. Under the same magnetic conditions, Tat-
conjugated Fe3O4@SiO2-Amino induced greater passage
ratio than non-conjugated ones. The increase could
result from an enhanced recognition and affinity to the
cells which sequentially triggered receptor-mediated
Fig. 7 The effect of external magnetic field (permanent magnet) on
the uptake of magnetic nanoparticles by hCMEC cells
Fig. 8 Transport efficiency of Fe3O4@SiO2-Tat and Fe3O4@SiO2-
Amino NPs
Fig. 6 Normalized dose–response for cell viability of Fe3O4@SiO2-Amino
and Fe3O4@SiO2-Tat NPs by MTT assay
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Fig. 9 Normalized TEER values of BBB model recorded after the introduction of nanoparticles with magnetic explosion periods. a Fe3O4@SiO2-
Amino NPs (F). b Fe3O4@SiO2-Tat NPs (FT)
Fig. 10 Flow cytometry of U251 cells containing NPs. a Control group; Fe3O4@SiO2-Amino NPs, b in the absence of magnetic field, and c under
magnetic explosion for 2 h; Fe3O4@SiO2-Tat NPs, d in the absence of magnetic field and e under magnetic explosion for 2 h. Higher intensity
along the x axis indicates more FACS delivery, and percentage of cells with internalized NPs is indicated
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endocytosis and increased accumulation of nanoparti-
cles in cells and the transportation [38]. It also was
reported that some PIONs covered by biomolecules
accumulated at a higher concentration in the tumors
when they were subjected to an external magnetic
field [27]. Hence, our prepared Fe3O4@SiO2-Tat NPs
have the potential to be magnetically mediated brain-
targeting carrier.
The effect of NPs across BBB was further evaluated by
monitoring the changes of the TEER before and after the
existence of NPs under the external magnetic field. As
shown in Fig. 9, the TEER values exhibited a similar
variation tendency, declining at 2 h incubation, and
reaching to the minimum at 8 h, then gradually recover-
ing and basically reaching more than 75 % of the initial
value at 26 h. This observation in good agreement with
the previous report [39] may be due to the fluctuations
of cell monolayer when introduction of extracellular
matters. Besides, the reduction of TEER values increased
with exposure time longing, and it is inversely to recov-
ery rate. NPs passage and accumulation did not harm
the integrity of in vitro BBB model.
Uptake and Location in U251
For an efficient brain-targeting therapy, the internaliza-
tion and accumulation of carriers in brain cells are also
important. To mimic a more realistic in vivo situation,
U251/hCMEC co-culture BBB model was built and used
to investigate uptake and location of nanoparticles in
U251 cells in the bottom chamber. As shown in Fig. 10,
Fe3O4@SiO2-Tat and Fe3O4@SiO2-Amino NPs, respect-
ively, increased 17.4- and 19.0-fold uptake by U251 cells
after 2 h explosion of magnetic field, compared with no-
magnet groups of 4.27 and 5.19 %. The result suggested
the application of external magnetic field greatly facili-
tated NPs internalization into the cells within the brain.
Moreover, the internalization of Fe3O4@SiO2-Tat was
higher than that of Fe3O4@SiO2-amino NPs whether or
not to apply a magnetic field, further reflecting trans-
membrane effect of Tat peptide.
For detecting the ultimate fate of NPs after passage
over BBB, FITC-labeled NPs was used as an optical
probe, and their intracellular localization in U251 cells
were analyze by CLSM after 2 h explosion of magnetic
field. As shown in Fig. 11, much more green dots of
Fig. 11 The localization of nanoparticles in U251 cells. a–c Fe3O4@SiO2-Amino NPs. d–f Fe3O4@SiO2-Tat NPs
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Fe3O4@SiO2-Tat distributed within cytoplasm compared
with non-conjugated ones, consistently in FCM results.
Moreover, the merged yellow fluorescent dots demon-
strated that almost of Tat-conjugated Fe3O4@SiO2-
Amino NPs accumulated in nucleus zone, indicating that
Fe3O4@SiO2-Tat NPs can enter into cell nucleus. In con-
trast, no green dots of Fe3O4@SiO2-Amino NPs were
detected in the blue nucleus district. It has been re-
ported that partly Tat-grafted nanoparticles can be cross
over nuclear membrane [40, 41]. Our findings may sug-
gest that a synergy effect of magnetic force and Tat pep-
tide can enhance cell internalization and nucleus
targeting.
Conclusions
To sum up, Tat-conjugated SiO2@Fe3O4 NPs exhibited
suitable magnetism and good biocompatibility. The
functionalization with Tat peptide facilitated particles to
pass through in vitro BBB and enter into the nucleus of
U251 glioma cells co-cultured at the bottom chamber.
Moreover, the synergistic effects of Tat and magnetic
field could promote the cell uptake of hCMEC cells and
entry to nuclear of U251, hence efficiently enhancing
permeability across BBB and subsequent accumulation
in glioma cells. It also found that Fe3O4@SiO2-Tat NPs
can be transported through the in vitro BBB via a trans-
cellular trafficking mechanism and magnetically medi-
ated dragging. Therefore, SiO2@Fe3O4-Tat NPs could be
exploited as a potential brain-targeting carrier for diag-
nosis and treatment of the brain disease.
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